📈 Today's Market Pulse

🎯 Today's Recap

Tuesday, July 21, 2026 delivered a broad market rally that felt less like a relief bounce and more like a statement. The S&P 500 climbed 0.89% to 7,509.20, the Nasdaq surged 1.29% to 25,837.21, and the Dow added 385 points. All three major indexes finished in the green, and the session had a refreshingly wide participation base.

Technology led the charge, but healthcare, industrials, and consumer names all showed up to the party. Breadth was solid, volume was healthy, and the mood across trading desks was notably constructive. This was not a market propped up by one or two mega-cap names. Real money moved into real ideas today.

Treasury yields ticked modestly higher, with the 10-year at 4.63% and the 30-year holding at 5.13%. The dollar index edged up to 101.18. Neither move was dramatic enough to rattle equities, and Bitcoin joined the optimism, climbing 1.82% to $66,417.

Nobody Scheduled the Last Two Booms. This One's Scheduled. [ad]

📊 Today's Market Movers

▲ Gainers AEHR ▲ +27.86% RGC ▲ +18.82% NBIS ▲ +18.78% CBRS ▲ +17.92% OUST ▲ +17.0%

▼ Losers BXBL ▼ -18.43% CHRN ▼ -12.15% DHR ▼ -10.92% MSCI ▼ -10.35% TENB ▼ -9.72%

🚀 What Moved Markets

The semiconductor rebound was the headline story of the session. Micron Technology (MU) exploded higher by more than $105, landing near $970. Analysts argued that the recent chip sell-off was a textbook overreaction, and that the growing adoption of open-source AI models will actually accelerate memory demand rather than threaten it. When the narrative flips that cleanly, the move tends to be sharp, and today proved exactly that.

Nvidia (NVDA) rode the same wave, with Wall Street analysts making the case that NVDA could be the defining earnings story of the season. Nebius Group (NBIS) added an eye-catching $34.30, reflecting broader investor enthusiasm for AI infrastructure plays. The chip sector did not just recover today, it reclaimed credibility.

Outside of tech, Gilead Sciences (GILD) and Merck (MRK) delivered a genuine headline. Their experimental once-weekly HIV pill successfully suppressed the virus in two late-stage trials. If approved, it would be the first treatment of its kind, a meaningful clinical and commercial milestone for both companies. Healthcare gave investors something real to get excited about today.

I Screened 23,000 Stocks. Only One Qualified [ad]

🎭 Investor Mood

The mood today felt like a market that decided to stop worrying and start positioning. The combination of a chip sector comeback, a potential breakthrough HIV treatment, and Tesla (TSLA) expanding its robotaxi service to Orlando and Tampa all landed in the same session. That is a lot of forward momentum to absorb in one day.

Apple (AAPL) added to the constructive backdrop with reports that it is launching a device leasing program called Apple Upgrade on July 28. The program targets U.S. consumers and is designed to drive recurring hardware upgrades. Subscription-style revenue models tend to command premium valuations, and investors noticed.

Even the deal flow supported the tone. Utz Brands (UTZ) agreed to be acquired by Germany's Intersnack Group in a $2.9 billion deal. Meanwhile, Kalshi made moves to launch perpetual precious metals futures after receiving CFTC approval in May. Markets with active deal activity and regulatory innovation tend to attract capital, and today's session reflected exactly that kind of environment.

Palantir just handed this company AI superpowers [ad]

🔍 Tomorrow's Watchlist

1. Watch MU and NVDA for follow-through as the chip rebound thesis gets tested over the next few sessions
2. Apple Upgrade launches July 28 - monitor analyst reactions to the leasing model and what it means for Services revenue
3. GILD and MRK HIV pill trial results are moving toward regulatory filings - healthcare investors should track that timeline
4. Tesla robotaxi expansion to Orlando and Tampa puts autonomous scale front and center ahead of earnings
5. Treasury yields holding near 4.63% on the 10-year - any further move higher could pressure rate-sensitive growth names

💸 The Takeaway

A few things deserve a closer look heading into the rest of the week. Tesla's robotaxi expansion is moving faster than most skeptics expected. Adding Orlando and Tampa ahead of an earnings report is not subtle. The company is clearly trying to put tangible scale on the board before management faces questions from analysts. Watch how that narrative develops.

The Airbus versus Boeing story is quietly getting interesting. Airbus is reportedly considering a longer version of its A350 that would directly challenge Boeing's troubled 777X. Boeing has enough problems without a serious competitor entering the jumbo jet category, and that competitive pressure is worth monitoring for aerospace investors.

Meta (META) had a rougher day in the headlines. Its AI-powered account moderation system reportedly banned users by mistake, and those users still had to rely on AI to fix the problem. The irony was not lost on anyone. Execution risk in AI deployment is real, and Meta is learning that lesson publicly. Tomorrow, keep an eye on chip momentum, Apple's leasing program details, and any further GILD or MRK commentary on their HIV trial results.

Dimon Says Banks Should Be "Scared S**tless" [ad]